2020 Annual Surveillance Report from Health Canada’s Consumer Product Safety Program
Advocacy & Action
Nitrosamine Update to Market Authorisation Holders of Human Pharmaceutical Products
Auditor General’s 2021 Report – Natural Health Products Program Released
Voluntary Information Gathering on Industry Supply Chain Information Sharing in Canada
An update on the proposed environmental risk assessment regulatory regime for drugs
Tabled for First Reading – Bill C-28, Strengthening Environmental Protection for a Healthier Canada Act (CEPA Renewal)
IAC Endorsed INCI position
Participate in RPRA’s proposed 2021 Registry fees consultation
Publication of the Final Screening Assessment for DTPMP
Meeting Summary: March 24 2021 – Performance standards for NHP applications
